AstraZeneca PLC is 253.3x more valuable than Schrodinger, Inc. by market capitalization ($286.27 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SDGR | AZN |
|---|---|---|
| Market cap | $1.13 B | $286.27 B |
| US-listed rank | #2556 | #45 |
| SEC filings | 516 | 1,004 |
AstraZeneca PLC is 253.3x more valuable than Schrodinger, Inc. by market capitalization ($286.27 B vs $1.13 B).
Full pages: Schrodinger, Inc. and AstraZeneca PLC, or browse the full rankings.